HIV switch study finds two drug combos equally effective
Disease control
Completed
This study looked at 558 people with HIV whose first treatment was no longer controlling the virus. Researchers compared two different second-line drug combinations: one with standard HIV drugs plus a booster, and another with a newer integrase inhibitor. After 48 weeks, both app…
Phase: PHASE4 • Sponsor: Kirby Institute • Aim: Disease control
Last updated May 14, 2026 12:03 UTC